China Life Insurance's New Business Value Growth Remains Bright Spot

Dow Jones11-02

0819 GMT - China Life Insurance's new business value growth in the nine months ended September remains a key bright spot despite the insurer's net profit missing estimates, says DBS Group Research's Ken Shih in a note. The insurer's new business value managed to maintain solid growth of around 13% on year despite the overall industry's decline, the analyst notes. The company is confident in its 2027 new business value growth outlook, citing the bancassurance channel's potential mid-to-long-term growth, he adds. Still, DBS cuts its 2026-2027 earnings projections by 20%-34% after the lower-than-expected net profit. The bank therefore trims its target price to 36.50 Hong Kong dollars from HK$38.00 but maintains a buy rating. Shares closed 3.85% higher at HK$24.80.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment